enGene Holdings, Inc. (ENGN)
8.40
-0.06
(-0.71%)
USD |
NASDAQ |
Dec 15, 16:00
8.40
0.00 (0.00%)
After-Hours: 19:03
enGene Holdings EPS Diluted (Quarterly): -0.5674 for July 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Achieve Life Sciences, Inc. | -0.2831 |
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 0.232 |
| Edesa Biotech, Inc. | -0.3157 |
| Lexaria Bioscience Corp. | -0.1378 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -28.99M |
| Total Expenses (Quarterly) | 28.99M |
| Enterprise Value | 395.13M |
| Earnings Yield | -22.57% |
| Normalized Earnings Yield | -22.57 |